Provided by Tiger Trade Technology Pte. Ltd.

SPYRE THERAPEUTICS INC

93.61
+4.585.14%
Volume:638.06K
Turnover:58.73M
Market Cap:8.25B
PE:-46.57
High:93.85
Open:89.13
Low:87.25
Close:89.03
52wk High:110.18
52wk Low:15.86
Shares:88.17M
Float Shares:80.98M
Volume Ratio:1.13
T/O Rate:0.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0100
EPS(LYR):-1.9755
ROE:-22.98%
ROA:-19.81%
PB:8.65
PE(LYR):-47.39

Loading ...

Spyre Therapeutics Inc : Deutsche Bank Raises Target Price to $88 From $55

THOMSON REUTERS
·
Apr 14

Spyre Therapeutics Inc : Jefferies Raises Target Price to $85 From $47

THOMSON REUTERS
·
Apr 14

BUZZ-Spyre drops on equity offering launch following inflammatory bowel drug trial

Reuters
·
Apr 14

BRIEF-Spyre Therapeutics Inc - Suspends And Terminates ATM Prospectus For At-The-Market Offering Effective April 13, 2026 - SEC Filing

Reuters
·
Apr 14

Spyre Therapeutics Launches $300 Million Stock Offering

MT Newswires Live
·
Apr 14

Spyre Therapeutics launches $300 million common stock offering

Reuters
·
Apr 14

Spyre Therapeutics Announces Proposed Public Offering of Its Common Stock

THOMSON REUTERS
·
Apr 14

Spyre Therapeutics Inc - Suspends and Terminates Atm Prospectus for at-the-Market Offering Effective April 13, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 14

Spyre data ‘exceptional,’ but combos could enable ‘dominance,’ says TD Cowen

TIPRANKS
·
Apr 14

Analysts’ Top Healthcare Picks: Oruka Therapeutics (ORKA), Spyre Therapeutics (SYRE)

TIPRANKS
·
Apr 14

Leerink sees Spyre’s SPY001 Phase 2 Data as incrementally positive for Oruka

TIPRANKS
·
Apr 14

Top Midday Gainers

MT Newswires Live
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune

Reuters
·
Apr 14

Spyre Therapeutics rises 24.2%

TIPRANKS
·
Apr 14

BUZZ-U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma

Reuters
·
Apr 13

Spyre Therapeutics Up Nearly 25%, on Track for Highest Close Since April 2022 -- Data Talk

Dow Jones
·
Apr 13

Sector Update: Health Care

MT Newswires Live
·
Apr 13

Spyre Therapeutics Shares Surge 23% in Pre-Market Trading

Deep News
·
Apr 13

Spyre Therapeutics Exec Says Spy001 Monotherapy Matched or Exceeded Efficacy Seen With Johnson & Johnson's Combination on Some Endpoints in Mid-Stage Study - Conf Call

THOMSON REUTERS
·
Apr 13

Spyre Shares up 23% Premarket After Co Says Inflammatory Bowel Drug Reduces Disease Activity in Mid-Stage Study

THOMSON REUTERS
·
Apr 13